News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Analysis of SCLC transcriptional factor subtypes finds differential CNS-specific outcomes – Memorial Sloan Kettering Radiation Oncology
May 20, 2024, 14:10

Analysis of SCLC transcriptional factor subtypes finds differential CNS-specific outcomes – Memorial Sloan Kettering Radiation Oncology

Memorial Sloan Kettering Radiation Oncology made the following post on X:

New by Dr. Kathryn Tringale, The Pike Lab: Small cell lung cancer often metastasizes to the brain & has poor prognosis. This analysis of SCLC lcsm transcriptional factor subtypes finds differential CNS-specific outcomes & may help guide personalized care.”

Read further.
Source: Memorial Sloan Kettering Radiation Oncology/X

brain metastases cancer Cancer research CNS-specific outcomes Dr. Kathryn Tringale Memorial Sloan Kettering Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology oncology analysis oncology findings personalized care personalized treatment prognosis radiation oncology Research SCLC small cell lung cancer The Pike Lab transcriptional factor subtypes
Special Coverage
Blog
Dec 30, 2024, 19:52
CelloType: A New Machine Learning Tool for Analyzing Cancer Cells and Tissues
Blog
Dec 30, 2024, 19:26
“QI Scholar Nursing Presentations Part 2” from the SIOP Nursing Network
Science
Dec 30, 2024, 13:52
Nico Gagelmann: Selected clinical studies 2024 in hematology
Insight
Dec 30, 2024, 13:43
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Blog
Dec 30, 2024, 13:42
Shaban Juma: The key to being one step ahead in the fight against cancer
Positive
Dec 30, 2024, 13:42
Improving the lives of children with cancer everywhere - St. Jude Children's Research Hospital
Blog
Dec 30, 2024, 13:37
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Insight
Dec 30, 2024, 13:35
James Crowley: Elevated expression of CCR7 is generally indicative of poor prognosis in cancers
Insight
Dec 30, 2024, 13:30
Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?
Insight
Dec 30, 2024, 13:23
Satya Prakash Yadav: 2024 blockbuster Menin inhibitor for infant ALL
Insight
Dec 30, 2024, 13:10
Promising response to lurbinectedin in NUT carcinoma by M.V. Sánchez Becerra et al. - Vivek Subbiah